Pre-order Enquiry
Request Free Sample
Global Real World Evidence Solutions Market Size, Status and Forecast 2018-2025
SKU ID : QYR-12925274 | Publishing Date : 17-Aug-2018 | No. of pages : 91
This report focuses on the global Real World Evidence Solutions status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Real World Evidence Solutions development in United States, Europe and China.
Real World Evidence is a worldwide trend in Health and Life Sciences. New kinds of data, such as electronic health records and data mining tools are now available and allow us to extract information and knowledge. We can detect medical treatment costs, treatment efficiency (cost, benefits, and risks), references to drugs, side effects, or long-term results.
In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.
In 2017, the global Real World Evidence Solutions market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Iqvia
IBM
Pharmaceutical Product Development
Parexel
United Health Group
Perkinelmer
Icon
Oracle
Cognizant
Syneos Health
Anthem
Clinigen
SAS Institute
Market segment by Type, the product can be split into
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
Market segment by Application, split into
Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Real World Evidence Solutions status, future forecast, growth opportunity, key market and key players.
To present the Real World Evidence Solutions development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Real World Evidence Solutions are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Real World Evidence is a worldwide trend in Health and Life Sciences. New kinds of data, such as electronic health records and data mining tools are now available and allow us to extract information and knowledge. We can detect medical treatment costs, treatment efficiency (cost, benefits, and risks), references to drugs, side effects, or long-term results.
In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R&D expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.
In 2017, the global Real World Evidence Solutions market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Iqvia
IBM
Pharmaceutical Product Development
Parexel
United Health Group
Perkinelmer
Icon
Oracle
Cognizant
Syneos Health
Anthem
Clinigen
SAS Institute
Market segment by Type, the product can be split into
Clinical Setting Data
Claims Data
Pharmacy Data
Patient Powered Data
Market segment by Application, split into
Pharmaceutical and Medical Device Companies
Healthcare Payers
Healthcare Providers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Real World Evidence Solutions status, future forecast, growth opportunity, key market and key players.
To present the Real World Evidence Solutions development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Real World Evidence Solutions are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
